Eton Pharmaceuticals, Inc. (ETON)
25.54
+0.50
(+2.00%)
USD |
NASDAQ |
Apr 20, 12:36
Eton Pharmaceuticals SG&A Expense (Quarterly) : 8.856M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 130.24M |
| Amicus Therapeutics, Inc. | 117.08M |
| Ovid Therapeutics, Inc. | 6.422M |
| Rhythm Pharmaceuticals, Inc. | 57.48M |
| Vir Biotechnology, Inc. | 23.62M |